QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2017     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs) 会议论文 作者:  Soo, R.;  Mok, T. S. K.;  Shi, Y-K.;  Zhang, L.;  Lu, S. 收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05 Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer) 期刊论文 ANNALS OF ONCOLOGY, 2017, 卷号: 28, 期号: 11 作者:  Nokihara, H.;  Lu, S.;  Mok, T. S. K.;  Nakagawa, K.;  Yamamoto, N. 收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05 docetaxel  non-inferiority  previously treated NSCLC  S-1  phase 3 study   Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer) 期刊论文 2017, 卷号: 28, 期号: 11, 页码: 2698-2706 作者:  Nokihara, H.;  Lu, S.;  Mok, T. S. K.;  Nakagawa, K.;  Yamamoto, N. 收藏  |  浏览/下载：30/0  |  提交时间：2020/01/03 docetaxel  non-inferiority  previously treated NSCLC  S-1  phase 3 study   EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs) 会议论文 ANNALS OF ONCOLOGY, 2017-11-01 作者:  Soo, R.;  Mok, T. S. K.;  Shi, Y-K.;  Zhang, L.;  Lu, S. 收藏  |  浏览/下载：28/0  |  提交时间：2020/01/04 EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs) 期刊论文 2017, 卷号: 28 作者:  Soo, R.;  Mok, T. S. K.;  Shi, Y-K.;  Zhang, L.;  Lu, S. 收藏  |  浏览/下载：16/0  |  提交时间：2020/01/04